Esperion Therapeutics, Inc. (ESPR): Price and Financial Metrics
ESPR Price/Volume Stats
| Current price | $1.22 | 52-week high | $3.94 |
| Prev. close | $1.16 | 52-week low | $0.69 |
| Day low | $1.18 | Volume | 5,324,720 |
| Day high | $1.27 | Avg. volume | 4,958,446 |
| 50-day MA | $1.00 | Dividend yield | N/A |
| 200-day MA | $1.78 | Market Cap | 241.80M |
ESPR Stock Price Chart Interactive Chart >
Esperion Therapeutics, Inc. (ESPR) Company Bio
Esperion Therapeutics is focused on developing and commercializing first-in-class, oral, LDL-cholesterol-lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. The company was founded in 1998 and is based in Ann Arbor, Michigan.
ESPR Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ESPR Price Returns
| 1-mo | 40.08% |
| 3-mo | -27.81% |
| 6-mo | -64.94% |
| 1-year | -50.61% |
| 3-year | -80.32% |
| 5-year | -97.31% |
| YTD | -44.55% |
| 2024 | -26.42% |
| 2023 | -52.01% |
| 2022 | 24.60% |
| 2021 | -80.77% |
| 2020 | -56.40% |